Maintaining hemodynamic stability in the pediatric organ donor
Maintaining hemodynamic stability in the pediatric organ donor
Hemodynamically stable
Hemodynamically unstable
Methylprednisolone
Levothyroxine OR triiodothyronine administration should be considered in this patient population
Diabetes insipidus
Desmopressin*
Continuous infusion (preferred)
Intermittent dose
OR
Vasopressin administered by continuous infusion
Volume loading with crystalloid or colloid
Inotropic support
Dopamine
Dobutamine
Epinephrine
Phenylephrine
Norepinephrine
Methylprednisolone
Bolus dose of levothyroxine followed by continuous infusion OR triiodothyronine infusion
Diabetes insipidus
Vasopressin administered by continuous infusion
* Desmopressin has a longer half-life than vasopressin. If desmopressin is used, it can be discontinued 2 to 3 hours prior to organ recovery to allow for its metabolism prior to the transplant procedure. Consultation with pediatric intensivists and transplant surgeons should occur to discuss preferences in pharmacologic agents used to maintain hemodynamic stability.